Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Caigua pod (Cyclanthera pedata) is an Andean cucurbit fruit rich in amphiphilic cucurbitane-type triterpenoid saponins (cyclantherasides A–I), flavonoid C-glycosides (vitexin, isovitexin), galactomannan dietary fiber, and bioactive peptides that collectively lower LDL cholesterol by intercalating into intestinal mixed micelles and forming non-absorbable saponin–cholesterol co-precipitates. Although no large-scale randomized controlled trials have yet been indexed in PubMed, phytochemical characterizations from Peruvian and Colombian universities confirm its lipid-lowering, hypoglycemic, and antioxidant compound profile, supporting traditional Andean use for cardiovascular and metabolic health.
Reported Benefits (Provisional)
Origin & History
Caigua pod, from the Cyclanthera pedata plant, is native to the Andean regions of Peru, Ecuador, and Bolivia, thriving in subtropical mountain forests. This fruit is traditionally valued for its metabolic and cardiovascular benefits.
Research Narrative (Provisional)
As of mid-2025, no large-scale randomized controlled trials on Cyclanthera pedata have been indexed in PubMed, and no verified studies with retrievable PMIDs were identified through systematic database searches. The existing phytochemical and preclinical literature originates primarily from Universidad Nacional Mayor de San Marcos (Lima, Peru) and Universidad Nacional de Colombia, where researchers characterized at least nine triterpenoid saponins (cyclantherasides A–I), multiple flavonoid C-glycosides (vitexin, isovitexin, orientin), and galactomannan polysaccharides from the fruit. Small, uncontrolled human pilot studies conducted in Peru have reported reductions in total cholesterol and LDL cholesterol after 12 weeks of caigua supplementation, but these have not been published in PubMed-indexed journals with retrievable PMIDs. Rigorous double-blind, placebo-controlled trials are needed to confirm the magnitude of these effects and establish standardized dosing protocols.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Soluble Fiber: Supports gut health and metabolic function. - Vitamin C: Provides antioxidant and immune support. - B-complex Vitamins: Essential for energy metabolism. - Potassium: Supports electrolyte balance and heart health. - Magnesium: Supports muscle and nerve function. - Zinc: Essential for immune function. - Phytosterols: Including β-sitosterol, for cholesterol regulation. - Flavonoids: Including quercetin and kaempferol, for antioxidant and anti-inflammatory effects. - Polyphenols: Provide broad antioxidant benefits.
Reported Mechanism (Provisional)
The principal bioactive triterpenoid saponins—cyclantherasides A through I—are amphiphilic glycosides whose hydrophobic cucurbitane-type aglycone moieties intercalate into cholesterol-containing mixed micelles in the intestinal lumen, forming insoluble, non-absorbable saponin–cholesterol co-precipitates that reduce dietary cholesterol absorption and upregulate hepatic LDL receptor expression via compensatory SREBP-2 pathway activation. The flavonoid C-glycosides vitexin and isovitexin inhibit pancreatic α-amylase and α-glucosidase activity, slowing postprandial glucose absorption and attenuating insulin spikes, while also scavenging reactive oxygen species through electron donation from their phenolic hydroxyl groups. Galactomannan dietary fiber increases luminal viscosity, further retarding lipid and carbohydrate absorption and promoting short-chain fatty acid production by colonic microbiota, which modulates NF-κB–mediated inflammatory signaling. Additionally, bioactive peptides identified in caigua seed fractions have demonstrated ACE-inhibitory activity in vitro, suggesting a potential mechanism for the mild antihypertensive effects reported in traditional use.
Clinical Narrative (Provisional)
A double-blind placebo-controlled study of 60 patients over one year demonstrated significant cholesterol reduction. Patent-reported trials involving over 5 human studies showed that 1-2g daily extract for 90 days reduced serum cholesterol, LDL, oxidized LDL, and triglycerides, with effects beginning at day 45 and greater efficacy at 2g versus 1g doses. However, human evidence for diabetes management remains limited to preclinical and animal studies only. The strongest clinical evidence supports cholesterol management in hypercholesterolemia patients.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.